Israel - hebraisk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - ox bile extract; pancreatin - דרז'ה - pancreatin 72 mg; ox bile extract 35 mg - multienzymes and acid preparations - multienzymes and acid preparations - regulation of digestive disturbances, indigestion fermentative dyspepsia, gastroenteritis, meteorism, epigastric fullness and post prandial distress.

Israel - hebraisk - Ministry of Health

takeda israel ltd - mesalazine - טבליות בשחרור ממושך - mesalazine 1200 mg - mesalazine

Israel - hebraisk - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 30 mg - duloxetine

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - loperamide hydrochloride - קפסולות - loperamide hydrochloride 2 mg - loperamide - loperamide - acute diarrhoea.

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - budesonide - קפסולות - budesonide 3 mg - budesonide - budesonide - for the induction and maintenance of remission in patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.

Israel - hebraisk - Ministry of Health

j-c health care ltd - oxybutynin chloride - טבליות בשחרור ממושך - oxybutynin chloride 5 mg - oxybutynin - oxybutynin - once daily controlled-release tablet indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

Israel - hebraisk - Ministry of Health

j-c health care ltd - oxybutynin chloride - טבליות בשחרור ממושך - oxybutynin chloride 10 mg - oxybutynin - oxybutynin - once daily controlled-release tablet indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

Israel - hebraisk - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

Israel - hebraisk - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

Israel - hebraisk - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.